NMS-873 Leads to Dysfunctional Glycometabolism in A p97-Independent Manner in HCT116 Colon Cancer Cells

Adenosine triphosphate (ATP)–competitive p97 inhibitor CB-5339, the successor of CB-5083, is being evaluated in Phase 1 clinical trials for anti-cancer therapy. Different modes-of-action p97 inhibitors such as allosteric inhibitors are useful to overcome drug-induced resistance, one of the major pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shan, Wang, Feng, Zhang, Gang, Chou, Tsui-Fen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024726/
https://www.ncbi.nlm.nih.gov/pubmed/35456598
http://dx.doi.org/10.3390/pharmaceutics14040764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024726/
https://www.ncbi.nlm.nih.gov/pubmed/35456598
http://dx.doi.org/10.3390/pharmaceutics14040764

Ejemplares similares